Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly Bolotin

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Plos One|July 24, 2008
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaRoss J Davidson, Ian Davis, Barbara M Willey, et al.
Pediatrics|November 23, 2019
Measles Antibody Levels in Young InfantsMichelle Science, Rachel Savage, Alberto Severini, et al.
Vaccine|October 12, 2023
Immunity of Canadians and risk of epidemics workshop - Conference reportShelly Bolotin, Selma Osman, Scott Halperin, et al.
The Journal of Infectious Diseases|November 2, 2019
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic ReviewShelly Bolotin, Stephanie L Hughes, Nazish Gul, et al.
Microbiology Spectrum|January 10, 2023
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of HealthSheila F O'Brien, Niamh Caffrey, Qi-Long Yi, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 28, 2016
Effectiveness of pertussis vaccination and duration of immunityKevin L Schwartz, Jeffrey C Kwong, Shelley L Deeks, et al.
Plos One|November 10, 2023
Maternal varicella antibodies in children aged less than one year: Assessment of antibody decayShelly Bolotin, Stephanie L Hughes, Rachel D Savage, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
Vaccine|April 11, 2019
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015Natasha S Crowcroft, Kevin L Schwartz, Cynthia Chen, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Plos One|July 24, 2008
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaRoss J Davidson, Ian Davis, Barbara M Willey, et al.
Pediatrics|November 23, 2019
Measles Antibody Levels in Young InfantsMichelle Science, Rachel Savage, Alberto Severini, et al.
Vaccine|October 12, 2023
Immunity of Canadians and risk of epidemics workshop - Conference reportShelly Bolotin, Selma Osman, Scott Halperin, et al.
The Journal of Infectious Diseases|November 2, 2019
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic ReviewShelly Bolotin, Stephanie L Hughes, Nazish Gul, et al.
Microbiology Spectrum|January 10, 2023
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of HealthSheila F O'Brien, Niamh Caffrey, Qi-Long Yi, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 28, 2016
Effectiveness of pertussis vaccination and duration of immunityKevin L Schwartz, Jeffrey C Kwong, Shelley L Deeks, et al.
Plos One|November 10, 2023
Maternal varicella antibodies in children aged less than one year: Assessment of antibody decayShelly Bolotin, Stephanie L Hughes, Rachel D Savage, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
Vaccine|April 11, 2019
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015Natasha S Crowcroft, Kevin L Schwartz, Cynthia Chen, et al.
Pageof 9